NCT07920042Not yet recruiting
A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
T2D is a chronic disease that forces people with diabetes to take their medications as prescribed and adhere to the recommended self-care practices to control their blood sugar and prevent complications. For a few patients, however, poor medication adherence is a problem due to forgetfulness, medication concerns, side effects, scheduling of medications in daily life, lack of access to medication, or lack of social support. Researchers want to see whether a customized nurse-led counseling service is effective in enhancing adherence to diabetes medications for adults with type 2 diabetes in a randomized controlled trial. The study will also explore the impact of the intervention on glycated hemoglobin (HbA1c) levels when compared to usual care. Participants who meet the criteria will be randomly assigned to either an intervention group or a usual care control group. Intervention group will be given a structured nurse-led counseling program, tailored to them, for 5 consecutive days. Assessment of medication taking barriers, providing education on medication adherence, problem solving strategies, individual goal setting, and development of a personal action plan will be incorporated into the program. A primary identified barrier to medication adherence will be identified and used to guide the counseling provided. The participants in the control group will be provided with standard diabetes care, as provided by the study site's services. Prespecified outcomes will be measured at baseline and at follow-up, including adherence to medication. HbA1c will be determined per study protocol to assess glycemic control. The results could guide the potential for a brief, individualized nurse-led counselling program as a feasible intervention for promoting adherence to treatment and self-management of diabetes in adults with type 2 diabetes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- First submitted
- 31 Oct 2026
- Start date
- 15 Nov 2026
- Primary completion date
- 20 Jun 2027
- Lead sponsor
- University of Basrah
- Diseases
- Type 2 diabetes
- NCT number
- NCT07920042
What you commit to
- Study type: Interventional
- Planned participants: 128
- From 15 Nov 2026 to the primary completion date, 20 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals who are unable to complete the planned follow-up assessments.
- **Study Population**
- The study will include adult patients with type 2 diabetes mellitus receiving routine diabetes care at the selected study setting.
Other illness
- Individuals diagnosed with type 1 diabetes mellitus or gestational diabetes.
- Individuals with an acute medical condition requiring hospitalization at the time of recruitment.
- Individuals currently participating in another structured diabetes self-management intervention or clinical trial that may interfere with the study outcomes.
Other
- Individuals with severe cognitive or communication impairments that prevent participation in the counseling intervention or completion of study assessments.
Who the study is looking for
- Adults aged 18 years or older.
- Individuals with a confirmed medical diagnosis of type 2 diabetes mellitus.
- Individuals currently receiving prescribed pharmacological treatment for type 2 diabetes mellitus (oral antidiabetic medications and/or injectable glucose-lowering medications).
- Individuals who are able to communicate effectively with the research team.
- Individuals who are willing and able to provide written informed consent.
- Individuals who are available to participate in the counseling intervention and complete the scheduled follow-up assessments.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| College of Nursing, University of Basrah Coordinator of this site? Confirm its status | Basra | Iraq | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.